Drug Shortage Report for RAN-CEFPROZIL

Last updated on 2019-02-04 History
Report ID 38637
Drug Identification Number 02293579
Brand name RAN-CEFPROZIL
Common or Proper name RAN-CEFPROZIL
Company Name RANBAXY PHARMACEUTICALS CANADA INC.
Active Ingredient(s) CEFPROZIL
Strength(s) 250MG
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL
Packaging size 100
ATC code J01DC
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-02-05
Actual start date 2018-02-05
Estimated end date 2019-03-01
Actual end date 2018-12-28
Shortage status Resolved
Updated date 2019-02-04
Company comments
Health Canada comments
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2019-02-04 French Compare
v12 2019-02-04 English Compare
v11 2019-01-17 French Compare
v10 2019-01-17 English Compare
v9 2018-12-12 French Compare
v8 2018-12-12 English Compare
v7 2018-11-27 French Compare
v6 2018-11-27 English Compare
v5 2018-08-23 French Compare
v4 2018-08-23 English Compare
v3 2018-02-06 English Compare
v2 2018-02-05 French Compare
v1 2018-02-05 English Compare